Cholesterol metabolism and cancer: Molecular mechanisms, immune regulation and an epidemiological perspective (Review)

Luo J, Yang H and Song BL: Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 21:225–245. 2020. View Article : Google Scholar

Ouimet M, Barrett TJ and Fisher EA: HDL and reverse cholesterol transport. Circ Res. 124:1505–1518. 2019. View Article : Google Scholar : PubMed/NCBI

Kuzu OF, Noory MA and Robertson GP: The role of cholesterol in cancer. Cancer Res. 76:2063–2070. 2016. View Article : Google Scholar : PubMed/NCBI

Cao D and Liu H: Dysregulated cholesterol regulatory genes in hepatocellular carcinoma. Eur J Med Res. 28:5802023. View Article : Google Scholar : PubMed/NCBI

Geng F and Guo D: SREBF1/SREBP-1 concurrently regulates lipid synthesis and lipophagy to maintain lipid homeostasis and tumor growth. Autophagy. 20:1183–1185. 2024. View Article : Google Scholar :

Goossens P, Rodriguez-Vita J, Etzerodt A, Masse M, Rastoin O, Gouirand V, Ulas T, Papantonopoulou O, Van Eck M, Auphan-Anezin N, et al: Membrane cholesterol efflux drives tumor-associated macrophage reprogramming and tumor progression. Cell Metab. 29:1376–1389.e4. 2019. View Article : Google Scholar : PubMed/NCBI

Spann NJ and Glass CK: Sterols and oxysterols in immune cell function. Nat Immunol. 14:893–900. 2013. View Article : Google Scholar : PubMed/NCBI

Miller WL and Auchus RJ: The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev. 32:81–151. 2011. View Article : Google Scholar

Simons K and Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 1:31–39. 2000. View Article : Google Scholar

Riscal R, Skuli N and Simon MC: Even cancer cells watch their cholesterol! Mol Cell. 76:220–231. 2019. View Article : Google Scholar : PubMed/NCBI

Ma X, Xiao L, Liu L, Ye L, Su P, Bi E, Wang Q, Yang M, Qian J and Yi Q: CD36-mediated ferroptosis dampens intratumoral CD8⁺ T cell effector function and impairs their antitumor ability. Cell Metab. 33:1001–1012.e5. 2021. View Article : Google Scholar

Gabitova-Cornell L, Surumbayeva A, Peri S, Franco-Barraza J, Restifo D, Weitz N, Ogier C, Goldman AR, Hartman TR, Francescone R, et al: Cholesterol pathway inhibition induces TGF-β signaling to promote basal differentiation in pancreatic cancer. Cancer Cell. 38:567–583.e11. 2020. View Article : Google Scholar

Liu W, Chakraborty B, Safi R, Kazmin D, Chang CY and McDonnell DP: Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer. Nat Commun. 12:51032021. View Article : Google Scholar : PubMed/NCBI

Yan C, Zheng L, Jiang S, Yang H, Guo J, Jiang LY, Li T, Zhang H, Bai Y, Lou Y, et al: Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity. Cancer Cell. 41:1276–1293.e11. 2023. View Article : Google Scholar : PubMed/NCBI

Luo M, Bao L, Chen Y, Xue Y, Wang Y, Zhang B, Wang C, Corley CD, McDonald JG, Kumar A, et al: ZMYND8 is a master regulator of 27-hydroxycholesterol that promotes tumorigenicity of breast cancer stem cells. Sci Adv. 8:eabn52952022. View Article : Google Scholar : PubMed/NCBI

Hu C, Qiao W, Li X, Ning ZK, Liu J, Dalangood S, Li H, Yu X, Zong Z, Wen Z and Gui J: Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8⁺T cells. Cell Metab. 36:630–647.e8. 2024. View Article : Google Scholar

Yarmolinsky J, Bull CJ, Vincent EE, Robinson J, Walther A, Smith GD, Lewis SJ, Relton CL and Martin RM: Association between genetically proxied inhibition of HMG-CoA reductase and epithelial ovarian cancer. JAMA. 323:646–655. 2020. View Article : Google Scholar : PubMed/NCBI

Kawamura S, Matsushita Y, Kurosaki S, Tange M, Fujiwara N, Hayata Y, Hayakawa Y, Suzuki N, Hata M, Tsuboi M, et al: Inhibiting SCAP/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis. J Clin Invest. 132:e1518952022. View Article : Google Scholar : PubMed/NCBI

Li C, Wang Y, Liu D, Wong CC, Coker OO, Zhang X, Liu C, Zhou Y, Liu Y, Kang W, et al: Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis. Gut. 71:2253–2265. 2022. View Article : Google Scholar : PubMed/NCBI

Fan J, Lin R, Xia S, Chen D, Elf SE, Liu S, Pan Y, Xu H, Qian Z, Wang M, et al: Tetrameric Acetyl-CoA acetyltransferase 1 is important for tumor growth. Mol Cell. 64:859–874. 2016. View Article : Google Scholar : PubMed/NCBI

Viaud M, Abdel-Wahab O, Gall J, Ivanov S, Guinamard R, Sore S, Merlin J, Ayrault M, Guilbaud E, Jacquel A, et al: ABCA1 exerts tumor-suppressor function in myeloproliferative neoplasms. Cell Rep. 30:3397–3410.e5. 2020. View Article : Google Scholar : PubMed/NCBI

Roundhill EA, Jabri S and Burchill SA: ABCG1 and Pgp identify drug resistant, self-renewing osteosarcoma cells. Cancer Lett. 453:142–157. 2019. View Article : Google Scholar : PubMed/NCBI

Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H, et al: Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med. 10:1344–1351. 2004. View Article : Google Scholar : PubMed/NCBI

Ioannou GN, Morrow OB, Connole ML and Lee SP: Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population. Hepatology. 50:175–184. 2009. View Article : Google Scholar : PubMed/NCBI

Xu R, Shen J, Song Y, Lu J, Liu Y, Cao Y, Wang Z and Zhang J: Exploration of the application potential of serum multi-biomarker model in colorectal cancer screening. Sci Rep. 14:101272024. View Article : Google Scholar : PubMed/NCBI

Jamnagerwalla J, Howard LE, Allott EH, Vidal AC, Moreira DM, Castro-Santamaria R, Andriole GL, Freeman MR and Freedland SJ: Serum cholesterol and risk of high-grade prostate cancer: Results from the REDUCE study. Prostate Cancer Prostatic Dis. 21:252–259. 2018. View Article : Google Scholar :

Zhao B, Gan L, Graubard BI, Männistö S, Albanes D and Huang J: Associations of dietary cholesterol, serum cholesterol, and egg consumption with overall and cause-specific mortality: Systematic review and updated meta-analysis. Circulation. 145:1506–1520. 2022. View Article : Google Scholar : PubMed/NCBI

Demierre MF, Higgins PD, Gruber SB, Hawk E and Lippman SM: Statins and cancer prevention. Nat Rev Cancer. 5:930–942. 2005. View Article : Google Scholar : PubMed/NCBI

Siemianowicz K, Gminski J, Stajszczyk M, Wojakowski W, Goss M, Machalski M, Telega A, Brulinski K and Magiera-Molendowska H: Serum total cholesterol and triglycerides levels in patients with lung cancer. Int J Mol Med. 5:201–205. 2000.PubMed/NCBI

Zhou P, Li B, Liu B, Chen T and Xiao J: Prognostic role of serum total cholesterol and high-density lipoprotein cholesterol in cancer survivors: A systematic review and meta-analysis. Clin Chim Acta. 477:94–104. 2018. View Article : Google Scholar

Oh MJ, Han K, Kim B, Lim JH, Kim B, Kim SG and Cho SJ: Risk of gastric cancer in relation with serum cholesterol profiles: A nationwide population-based cohort study. Medicine (Baltimore). 102:e362602023. View Article : Google Scholar : PubMed/NCBI

Zhang X, Coker OO, Chu ES, Fu K, Lau HCH, Wang YX, Chan AWH, Wei H, Yang X, Sung JJY and Yu J: Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. Gut. 70:761–774. 2021. View Article : Google Scholar

Zhang X, Ding HM, Deng LF, Chen GC, Li J, He ZY, Fu L, Li JF, Jiang F, Zhang ZL and Li BY: Dietary fats and serum lipids in relation to the risk of ovarian cancer: A meta-analysis of observational studies. Front Nutr. 10:11539862023. View Article : Google Scholar : PubMed/NCBI

Ikonen E and Olkkonen VM: Intracellular cholesterol trafficking. Cold Spring Harb Perspect Biol. 15:a0414042023. View Article : Google Scholar : PubMed/NCBI

von Eckardstein A, Nordestgaard BG, Remaley AT and Catapano AL: High-density lipoprotein revisited: Biological functions and clinical relevance. Eur Heart J. 44:1394–1407. 2023. View Article : Google Scholar :

Dang EV and Reboldi A: Cholesterol sensing and metabolic adaptation in tissue immunity. Trends Immunol. 45:861–870. 2024. View Article : Google Scholar : PubMed/NCBI

Griffiths WJ and Wang Y: Cholesterol metabolism: From lipidomics to immunology. J Lipid Res. 63:1001652022. View Article : Google Scholar :

Long T, Debler EW and Li X: Structural enzymology of cholesterol biosynthesis and storage. Curr Opin Struct Biol. 74:1023692022. View Article : Google Scholar : PubMed/NCBI

Schade DS, Shey L and Eaton RP: Cholesterol review: A metabolically important molecule. Endocr Pract. 26:1514–1523. 2020. View Article : Google Scholar

Halimi H and Farjadian S: Cholesterol: An important actor on the cancer immune scene. Front Immunol. 13:10575462022. View Article : Google Scholar : PubMed/NCBI

Goicoechea L, Conde de la Rosa L, Torres S, García-Ruiz C and Fernández-Checa JC: Mitochondrial cholesterol: Metabolism and impact on redox biology and disease. Redox Biol. 61:1026432023. View Article : Google Scholar : PubMed/NCBI

Meng Y, Heybrock S, Neculai D and Saftig P: Cholesterol handling in lysosomes and beyond. Trends Cell Biol. 30:452–466. 2020. View Article : Google Scholar : PubMed/NCBI

Feingold KR: Lipid and lipoprotein metabolism. Endocrinol Metab Clin North Am. 51:437–458. 2022. View Article : Google Scholar : PubMed/NCBI

Chandel NS: Lipid metabolism. Cold Spring Harb Perspect Biol. 13:a0405762021. View Article : Google Scholar : PubMed/NCBI

Xiao X, Kennelly JP, Ferrari A, Clifford BL, Whang E, Gao Y, Qian K, Sandhu J, Jarrett KE, Brearley-Sholto MC, et al: Hepatic nonvesicular cholesterol transport is critical for systemic lipid homeostasis. Nat Metab. 5:165–181. 2023. View Article : Google Scholar : PubMed/NCBI

Kennelly JP and Tontonoz P: Cholesterol transport to the endoplasmic reticulum. Cold Spring Harb Perspect Biol. 15:a0412632023. View Article : Google Scholar

Faulkner RA, Yang Y, Tsien J, Qin T and DeBose-Boyd RA: Direct binding to sterols accelerates endoplasmic reticulum-associated degradation of HMG CoA reductase. Proc Natl Acad Sci USA. 121:e23188221212024. View Article : Google Scholar : PubMed/NCBI

Chen L, Zhao ZW, Zeng PH, Zhou YJ and Yin WJ: Molecular mechanisms for ABCA1-mediated cholesterol efflux. Cell Cycle. 21:1121–1139. 2022. View Article : Google Scholar : PubMed/NCBI

Hu X, Chen F, Jia L, Long A, Peng Y, Li X, Huang J, Wei X, Fang X, Gao Z, et al: A gut-derived hormone regulates cholesterol metabolism. Cell. 187:1685–1700.e18. 2024. View Article : Google Scholar : PubMed/NCBI

Saher G: Cholesterol metabolism in aging and age-related disorders. Annu Rev Neurosci. 46:59–78. 2023. View Article : Google Scholar : PubMed/NCBI

Xu H, Zhou S, Tang Q, Xia H and Bi F: Cholesterol metabolism: New functions and therapeutic approaches in cancer. Biochim Biophys Acta Rev Cancer. 1874:1883942020. View Article : Google Scholar : PubMed/NCBI

Mittal S, Nenwani M, Pulikkal Kadamberi I, Kumar S, Animasahun O, George J, Tsaih SW, Gupta P, Singh M, Geethadevi A, et al: eIF4E enriched extracellular vesicles induce immunosuppressive macrophages through HMGCR-mediated metabolic rewiring. Adv Sci (Weinh). e063072025.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI

Ashida S, Kawada C and Inoue K: Stromal regulation of prostate cancer cell growth by mevalonate pathway enzymes HMGCS1 and HMGCR. Oncol Lett. 14:6533–6542. 2017.PubMed/NCBI

Martin OP, Wallace MS, Oetheimer C, Patel HB, Butler MD, Wong LP, Huang P, Elbaz J, Costentin C, Salloum S, et al: Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesis. Nat Immunol. 26:1596–1611. 2025. View Article : Google Scholar : PubMed/NCBI

Saito Y, Yin D, Kubota N, Wang X, Filliol A, Remotti H, Nair A, Fazlollahi L, Hoshida Y, Tabas I, et al: A therapeutically targetable TAZ-TEAD2 pathway drives the growth of hepatocellular carcinoma via ANLN and KIF23. Gastroenterology. 164:1279–1292. 2023. View Article : Google Scholar : PubMed/NCBI

Li Z, Liu C, Wang M, Wei R, Li R, Huang K, Liang H, Li G and Zhao L: Cholesterol confers resistance to Apatinib-mediated ferroptosis in gastric cancer. Cell Biosci. 15:952025. View Article : Google Scholar : PubMed/NCBI

Li MX, Hu S, Lei HH, Yuan M, Li X, Hou WK, Huang XJ, Xiao BW, Yu TX, Zhang XH, et al: Tumor-derived miR-9-5p-loaded EVs regulate cholesterol homeostasis to promote breast cancer liver metastasis in mice. Nat Commun. 15:105392024. View Article : Google Scholar : PubMed/NCBI

Xue X, He Z, Liu F, Wang Q, Chen Z, Lin L, Chen D, Yuan Y, Huang Z and Wang Y: Taurochenodeoxycholic acid suppresses the progression of glioblastoma via HMGCS1/HMGCR/GPX4 signaling pathway in vitro and in vivo. Cancer Cell Int. 25:1602025. View Article : Google Scholar : PubMed/NCBI

Nakagawa H: Lipogenesis and MASLD: Re-thinking the role of SREBPs. Arch Toxicol. 99:2299–2312. 2025. View Article : Google Scholar : PubMed/NCBI

Li Y, Wu S, Zhao X, Hao S, Li F, Wang Y, Liu B, Zhang D, Wang Y and Zhou H: Key events in cancer: Dysregulation of SREBPs. Front Pharmacol. 14:11307472023. View Article : Google Scholar : PubMed/NCBI

Geng F, Zhong Y, Su H, Lefai E, Magaki S, Cloughesy TF, Yong WH, Chakravarti A and Guo D: SREBP-1 upregulates lipophagy to maintain cholesterol homeostasis in brain tumor cells. Cell Rep. 42:1127902023. View Article : Google Scholar : PubMed/NCBI

Chen Y, Deng X, Li Y, Han Y, Peng Y, Wu W, Wang X, Ma J, Hu E, Zhou X, et al: Comprehensive molecular classification predicted microenvironment profiles and therapy response for HCC. Hepatology. 80:536–551. 2024. View Article : Google Scholar : PubMed/NCBI

Zhou J, Qu G, Zhang G, Wu Z, Liu J, Yang D, Li J, Chang M, Zeng H, Hu J, et al: Glycerol kinase 5 confers gefitinib resistance through SREBP1/SCD1 signaling pathway. J Exp Clin Cancer Res. 38:962019. View Article : Google Scholar : PubMed/NCBI

Su F and Koeberle A: Regulation and targeting of SREBP-1 in hepatocellular carcinoma. Cancer Metastasis Rev. 43:673–708. 2024. View Article : Google Scholar :

Chen F, Li H, Wang Y, Tang X, Lin K, Li Q, Meng C, Shi W, Leo J, Liang X, et al: CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors. Nat Cancer. 6:854–873. 2025. View Article : Google Scholar : PubMed/NCBI

Gao W, Guo X, Sun L, Gai J, Cao Y and Zhang S: PKMYT1 knockdown inhibits cholesterol biosynthesis and promotes the drug sensitivity of triple-negative breast cancer cells to atorvastatin. PeerJ. 12:e177492024. View Article : Google Scholar : PubMed/NCBI

Wu R, Li N, Huang W, Yang Y, Zang R, Song H, Shi J, Zhu S and Liu Q: Melittin suppresses ovarian cancer growth by regulating SREBP1-mediated lipid metabolism. Phytomedicine. 137:1563672025. View Article : Google Scholar : PubMed/NCBI

Wen J, Zhang X, Wong CC, Zhang Y, Pan Y, Zhou Y, Cheung AH, Liu Y, Ji F, Kang X, et al: Targeting squalene epoxidase restores anti-PD-1 efficacy in metabolic dysfunction-associated steatohepatitis-induced hepatocellular carcinoma. Gut. 73:2023–2036. 2024. View Article : Google Scholar : PubMed/NCBI

Li J, Yang T, Wang Q, Li Y, Wu H, Zhang M, Qi H, Zhang H and Li J: Upregulation of SQLE contributes to poor survival in head and neck squamous cell carcinoma. Int J Biol Sci. 18:3576–3591. 2022. View Article : Google Scholar : PubMed/NCBI

Liu Q, Zhang Y, Li H, Gao H, Zhou Y, Luo D, Shan Z, Yang Y, Weng J, Li Q, et al: Squalene epoxidase promotes the chemoresistance of colorectal cancer via (S)-2,3-epoxysqualene-activated NF-κB. Cell Commun Signal. 22:2782024. View Article : Google Scholar

Wu J, Hu W, Yang W, Long Y, Chen K, Li F, Ma X and Li X: Knockdown of SQLE promotes CD8+ T cell infiltration in the tumor microenvironment. Cell Signal. 114:1109832024. View Article : Google Scholar

Xu M, Pan G, Zhang Q, Huang J, Wu Y and Ashan Y: FOXM1 boosts glycolysis by upregulating SQLE to inhibit anoikis in breast cancer cells. J Cancer Res Clin Oncol. 151:1622025. View Article : Google Scholar : PubMed/NCBI

Shen T, Lu Y and Zhang Q: High squalene epoxidase in tumors predicts worse survival in patients with hepatocellular carcinoma: Integrated bioinformatic analysis on NAFLD and HCC. Cancer Control. 27:10732748209146632020. View Article : Google Scholar : PubMed/NCBI

Zhang Z, Wu W, Jiao H, Chen Y, Ji X, Cao J, Yin F and Yin W: Squalene epoxidase promotes hepatocellular carcinoma development by activating STRAP transcription and TGF-β/SMAD signalling. Br J Pharmacol. 180:1562–1581. 2023. View Article : Google Scholar

Kanmalar M, Abdul Sani SF, Kamri NINB, Said NABM, Jamil AHBA, Kuppusamy S, Mun KS and Bradley DA: Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: A review. Cell Mol Biol Lett. 27:92022. View Article : Google Scholar : PubMed/NCBI

Cai D, Zhong GC, Dai X, Zhao Z, Chen M, Hu J, Wu Z, Cheng L, Li S and Gong J: Targeting FDFT1 reduces cholesterol and bile acid production and delays hepatocellular carcinoma progression through the HNF4A/ALDOB/AKT1 axis. Adv Sci (Weinh). 12:e24117192025. View Article : Google Scholar : PubMed/NCBI

Wu Z, Duan W, Xiong Y, Liu J, Wen X, Zhao F, Xiang D, Wang J, Kasim V and Wu S: NeuroD1 drives a KAT2A-FDFT1 signaling axis to promote cholesterol biosynthesis and hepatocellular carcinoma progression via histone H3K27 acetylation. Oncogene. Sep 1–2025.Epub ahead of print.

Yang C, Huang S, Cao F and Zheng Y: A lipid metabolism-related genes prognosis biomarker associated with the tumor immune microenvironment in colorectal carcinoma. BMC Cancer. 21:11822021. View Article : Google Scholar : PubMed/NCBI

Zhang HL, Zhao R, Wang D, Mohd Sapudin SN, Yahaya BH, Harun MSR, Zhang ZW, Song ZJ, Liu YT, Doblin S and Lu P: Candida albicans and colorectal cancer: A paradoxical role revealed through metabolite profiling and prognostic modeling. World J Clin Oncol. 16:1041822025. View Article : Google Scholar : PubMed/NCBI

Weng ML, Chen WK, Chen XY, Lu H, Sun ZR, Yu Q, Sun PF, Xu YJ, Zhu MM, Jiang N, et al: Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression. Nat Commun. 11:18692020. View Article : Google Scholar

Goudarzi A: The recent insights into the function of ACAT1: A possible anti-cancer therapeutic target. Life Sci. 232:1165922019. View Article : Google Scholar : PubMed/NCBI

Gu L, Zhu Y, Lin X, Tan X, Lu B and Li Y: Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis. Oncogene. 39:2437–2449. 2020. View Article : Google Scholar : PubMed/NCBI

Wang T, Wang G, Shan D, Fang Y, Zhou F, Yu M, Ju L, Li G, Xiang W, Qian K, et al: ACAT1 promotes proliferation and metastasis of bladder cancer via AKT/GSK3β/c-Myc signaling pathway. J Cancer. 15:3297–3312. 2024. View Article : Google Scholar :

Sun S, Qi G, Chen H, He D, Ma D, Bie Y, Xu L, Feng B, Pang Q, Guo H and Zhang R: Ferroptosis sensitization in glioma: Exploring the regulatory mechanism of SOAT1 and its therapeutic implications. Cell Death Dis. 14:7542023. View Article : Google Scholar : PubMed/NCBI

Wei C, Liao K, Chen HJ, Xiao ZX, Meng Q, Liu ZK, Lu YX, Sheng H, Mo HY, Wu QN, et al: Nuclear mitochondrial acetyl-CoA acetyltransferase 1 orchestrates natural killer cell-dependent antitumor immunity in colorectal cancer. Signal Transduct Target Ther. 10:1382025. View Article : Google Scholar : PubMed/NCBI

Kwon RJ, Park EJ, Lee SY, Lee Y, Hwang C, Kim C and Cho YH: Expression and prognostic significance of Niemann-Pick C1-Like 1 in colorectal cancer: A retrospective cohort study. Lipids Health Dis. 20:1042021. View Article : Google Scholar : PubMed/NCBI

Yin W, Ao Y, Jia Q, Zhang C, Yuan L, Liu S, Xiao W, Luo G, Shi X, Xin C, et al: Integrated singlecell and bulk RNA-seq analysis identifies a prognostic signature related to inflammation in colorectal cancer. Sci Rep. 15:8742025. View Article : Google Scholar : PubMed/NCBI

Yin Y, Wu C, Zhou Y, Zhang M, Mai S, Chen M and Wang HY: Ezetimibe INDUCES PARAPTOSIS THROUGH NIEMANN-PICK C1-like 1 inhibition of mammalian-target-of-rapamycin signaling in hepatocellular carcinoma cells. Genes (Basel). 15:42023. View Article : Google Scholar

Liu X, Lv M, Zhang W and Zhan Q: Dysregulation of cholesterol metabolism in cancer progression. Oncogene. 42:3289–3302. 2023. View Article : Google Scholar : PubMed/NCBI

Guo XJ, Zhu BB, Li J, Guo P, Niu YB, Shi JL, Yokoyama W, Huang QS and Shao DY: Cholesterol metabolism in tumor immunity: Mechanisms and therapeutic opportunities for cancer. Biochem Pharmacol. 234:1168022025. View Article : Google Scholar : PubMed/NCBI

Pan Z, Wang K, Wang X, Jia Z, Yang Y, Duan Y, Huang L, Wu ZX, Zhang JY and Ding X: Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression. Mol Cancer. 21:772022. View Article : Google Scholar

Rademaker G, Hernandez GA, Seo Y, Dahal S, Miller-Phillips L, Li AL, Peng XL, Luan C, Qiu L, Liegeois MA, et al: PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer. Nature. 643:1381–1390. 2025. View Article : Google Scholar : PubMed/NCBI

Fu R, Xue W, Liang J, Li X, Zheng J, Wang L, Zhang M and Meng J: SOAT1 regulates cholesterol metabolism to induce EMT in hepatocellular carcinoma. Cell Death Dis. 15:3252024. View Article : Google Scholar : PubMed/NCBI

Alvarado-Ortiz E, de la Cruz-López KG, Becerril-Rico J, Sarabia-Sánchez MA, Ortiz-Sánchez E and García-Carrancá A: Mutant p53 gain-of-function: Role in cancer development, progression, and therapeutic approaches. Front Cell Dev Biol. 8:6076702021. View Article : Google Scholar : PubMed/NCBI

Freed-Pastor WA, Mizuno H, Zhao X, Langerød A, Moon SH, Rodriguez-Barrueco R, Barsotti A, Chicas A, Li W, Polotskaia A, et al: Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell. 148:244–258. 2012. View Article : Google Scholar : PubMed/NCBI

Moon SH, Huang CH, Houlihan SL, Regunath K, Freed-Pastor WA, Morris JP IV, Tschaharganeh DF, Kastenhuber ER, Barsotti AM, Culp-Hill R, et al: p53 represses the mevalonate pathway to mediate tumor suppression. Cell. 176:564–580.e19. 2019. View Article : Google Scholar :

Zhang Y, Mohibi S, Vasilatis DM, Chen M, Zhang J and Chen X: Ferredoxin reductase and p53 are necessary for lipid homeostasis and tumor suppression through the ABCA1-SREBP pathway. Oncogene. 41:1718–1726. 2022. View Article : Google Scholar : PubMed/NCBI

Fan S, Guo J, Nie H, Xiong H and Xia Y: Aberrant energy metabolism in tumors and potential therapeutic targets. Genes Chromosomes Cancer. 63:e700082024. View Article : Google Scholar : PubMed/NCBI

Da Cruz Paula A, Zhu Y, Brown DN, Issa Bhaloo S, Pareja F, Hoang TJ, Green H, Basili T, Dopeso H, Selenica P, et al: Evolution and co-occurrence of PI3K pathway gene mutations in endometrial carcinoma molecular subtypes at the single-cell level. Clin Cancer Res. August 20–2025.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI

Kaysudu I, Gungul TB, Atici S, Yilmaz S, Bayram E, Guven G, Cizmecioglu NT, Sahin O, Yesiloz G, Haznedaroglu BZ and Cizmecioglu O: Cholesterol biogenesis is a PTEN-dependent actionable node for the treatment of endocrine therapy-refractory cancers. Cancer Sci. 114:4365–4375. 2023. View Article : Google Scholar : PubMed/NCBI

Fitzgerald TL, Lertpiriyapong K, Cocco L, Martelli AM, Libra M, Candido S, Montalto G, Cervello M, Steelman L, Abrams SL and McCubrey JA: Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells. Adv Biol Regul. 59:65–81. 2015. View Article : Google Scholar : PubMed/NCBI

Aylon Y and Oren M: The Hippo pathway, p53 and cholesterol. Cell Cycle. 15:2248–2255. 2016. View Article : Google Scholar : PubMed/NCBI

Eid W, Dauner K, Courtney KC, Gagnon A, Parks RJ, Sorisky A and Zha X: mTORC1 activates SREBP-2 by suppressing cholesterol trafficking to lysosomes in mammalian cells. Proc Natl Acad Sci USA. 114:7999–8004. 2017. View Article : Google Scholar : PubMed/NCBI

Deng YZ, Cai Z, Shi S, Jiang H, Shang YR, Ma N, Wang JJ, Guan DX, Chen TW, Rong YF, et al: Cilia loss sensitizes cells to transformation by activating the mevalonate pathway. J Exp Med. 215:177–195. 2018. View Article : Google Scholar :

Das S, Parigi SM, Luo X, Fransson J, Kern BC, Okhovat A, Diaz OE, Sorini C, Czarnewski P, Webb AT, et al: Liver X receptor unlinks intestinal regeneration and tumorigenesis. Nature. 637:1198–1206. 2025. View Article : Google Scholar :

Bakiri L, Hamacher R, Graña O, Guío-Carrión A, Campos-Olivas R, Martinez L, Dienes HP, Thomsen MK, Hasenfuss SC and Wagner EF: Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulation. J Exp Med. 214:1387–1409. 2017. View Article : Google Scholar : PubMed/NCBI

Deng CM, Zhang GG, Liu QW, Xu JJ, Liu ZC, Yang J, Xu TY, Li ZG, Zhang F and Li B: ANO1 reprograms cholesterol metabolism and the tumor microenvironment to promote cancer metastasis. Cancer Res. 83:1851–1865. 2023. View Article : Google Scholar : PubMed/NCBI

Zhou YX, Wei J, Deng G, Hu A, Sun PY, Zhao X, Song BL and Luo J: Delivery of low-density lipoprotein from endocytic carriers to mitochondria supports steroidogenesis. Nat Cell Biol. 25:937–949. 2023. View Article : Google Scholar : PubMed/NCBI

He W, Wang M, Zhang X, Wang Y, Zhao D, Li W, Lei F, Peng M, Zhang Z, Yuan Y and Huang Z: Estrogen induces LCAT to maintain cholesterol homeostasis and suppress hepatocellular carcinoma development. Cancer Res. 84:2417–2431. 2024. View Article : Google Scholar : PubMed/NCBI

Xian M, Wang Q, Xiao L, Zhong L, Xiong W, Ye L, Su P, Zhang C, Li Y, Orlowski RZ, et al: Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis. Nat Commun. 15:57672024. View Article : Google Scholar : PubMed/NCBI

De Oliveira-Gomes D, Joshi PH, Peterson ED, Rohatgi A, Khera A and Navar AM: Apolipoprotein B: Bridging the gap between evidence and clinical practice. Circulation. 150:62–79. 2024. View Article : Google Scholar : PubMed/NCBI

Gilliland T, Dron JS, Selvaraj MS, Trinder M, Paruchuri K, Urbut SM, Haidermota S, Bernardo R, Uddin MM, Honigberg MC, et al: Genetic architecture and clinical outcomes of combined lipid disturbances. Circ Res. 135:265–276. 2024. View Article : Google Scholar : PubMed/NCBI

Lee G, Jeong YS, Kim DW, Kwak MJ, Koh J, Joo EW, Lee JS, Kah S, Sim YE and Yim SY: Clinical significance of APOB inactivation in hepatocellular carcinoma. Exp Mol Med. 50:1–12. 2018. View Article : Google Scholar : PubMed/NCBI

Liu Z, Yuan H, Wang Y, Li K, Suo C, Jin L, Ding C and Chen X: Proteogenomic analysis identifies a causal association between plasma apolipoprotein B levels and liver cancer risk. J Proteome Res. 23:4055–4066. 2024. View Article : Google Scholar : PubMed/NCBI

Borgquist S, Butt T, Almgren P, Shiffman D, Stocks T, Orho-Melander M, Manjer J and Melander O: Apolipoproteins, lipids and risk of cancer. Int J Cancer. 138:2648–2656. 2016. View Article : Google Scholar : PubMed/NCBI

Guan Y, Liu X, Yang Z, Zhu X, Liu M, Du M, Pan X and Wang Y: PCSK9 promotes LDLR degradation by preventing SNX17-mediated LDLR recycling. Circulation. 151:1512–1526. 2025. View Article : Google Scholar : PubMed/NCBI

Yuan J, Cai T, Zheng X, Ren Y, Qi J, Lu X, Chen H, Lin H, Chen Z, Liu M, et al: Potentiating CD8⁺ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling. Protein Cell. 12:240–260. 2021. View Article : Google Scholar : PubMed/NCBI

Ma L, Zhang L, Li L and Zhao L: The function of lncRNA EMX2OS/miR-653-5p and its regulatory mechanism in lung adenocarcinoma. Open Med (Wars). 18:202306862023. View Article : Google Scholar : PubMed/NCBI

Chen Z, Chen L, Sun B, Liu D, He Y, Qi L, Li G, Han Z, Zhan L, Zhang S, et al: LDLR inhibition promotes hepatocellular carcinoma proliferation and metastasis by elevating intracellular cholesterol synthesis through the MEK/ERK signaling pathway. Mol Metab. 51:1012302021. View Article : Google Scholar : PubMed/NCBI

Zhu T, Tan JZA, Zhang L, Huang H, Das SS, Cheng F, Padmanabhan P, Jones MJK, Lee M, Lee A, et al: FTO suppresses DNA repair by inhibiting PARP1. Nat Commun. 16:29252025. View Article : Google Scholar : PubMed/NCBI

Alemasova EE and Lavrik OI: Poly(ADP-ribosyl)ation by PARP1: Reaction mechanism and regulatory proteins. Nucleic Acids Res. 47:3811–3827. 2019. View Article : Google Scholar : PubMed/NCBI

He Z, Gong S, Zhang X, Li J, Xue J, Zeng Q, Nie J, Zhang Z, Ding H, Pei H and Li B: Activated PARP1/FAK/COL5A1 signaling facilitates the tumorigenesis of cholesterol-resistant ovarian cancer cells through promoting EMT. Cell Signal. 124:1114192024. View Article : Google Scholar : PubMed/NCBI

Diestel A, Aktas O, Hackel D, Hake I, Meier S, Raine CS, Nitsch R, Zipp F and Ullrich O: Activation of microglial poly(ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: A link between demyelination and neuronal damage. J Exp Med. 198:1729–1740. 2003. View Article : Google Scholar : PubMed/NCBI

Farez MF, Quintana FJ, Gandhi R, Izquierdo G, Lucas M and Weiner HL: Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE. Nat Immunol. 10:958–964. 2009. View Article : Google Scholar : PubMed/NCBI

Lee DH, Nam YJ, Lee MS, Sohn DS and Lee CS: Rotundarpene attenuates cholesterol oxidation product-induced apoptosis by suppressing the mitochondrial pathway and the caspase-8- and bid-dependent pathways. Eur J Pharmacol. 749:39–48. 2015. View Article : Google Scholar : PubMed/NCBI

Batnasan E, Wang R, Wen J, Ke Y, Li X, Bohio AA, Zeng X, Huo H, Han L, Boldogh I and Ba X: 17-Beta estradiol inhibits oxidative stress-induced accumulation of AIF into nucleolus and PARP1-dependent cell death via estrogen receptor alpha. Toxicol Lett. 232:1–9. 2015. View Article : Google Scholar

Wang D, Li Y, Wang N, Luo G, Wang J, Luo C, Yu W and Hao L: 1α,25-Dihydroxyvitamin D₃ prevents renal oxidative damage via the PARP1/SIRT1/NOX4 pathway in Zucker diabetic fatty rats. Am J Physiol Endocrinol Metab. 318:E343–E356. 2020. View Article : Google Scholar

Allott EH, Howard LE, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL and Freedland SJ: Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH database. Cancer Epidemiol Biomarkers Prev. 23:2349–2356. 2014. View Article : Google Scholar : PubMed/NCBI

Xu R, Song J, Ruze R, Chen Y, Yin X, Wang C and Zhao Y: SQLE promotes pancreatic cancer growth by attenuating ER stress and activating lipid rafts-regulated Src/PI3K/Akt signaling pathway. Cell Death Dis. 14:4972023. View Article : Google Scholar : PubMed/NCBI

Zhang Z, Huang H, Chen Z, Yan M, Lu C, Xu Z and Li Z: Helicobacter pylori promotes gastric cancer through CagA-mediated mitochondrial cholesterol accumulation by targeting CYP11A1 redistribution. Int J Biol Sci. 20:4007–4028. 2024. View Article : Google Scholar : PubMed/NCBI

Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD, Hansen AS, Gouw AM and Felsher DW: The MYC oncogene-the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol. 19:23–36. 2022. View Article : Google Scholar

Yang F, Kou J, Liu Z, Li W and Du W: MYC enhances cholesterol biosynthesis and supports cell proliferation through SQLE. Front Cell Dev Biol. 9:6558892021. View Article : Google Scholar : PubMed/NCBI

Tan SH, Tan TK, Yokomori R, Liao M, Huang XZ, Yeoh AEJ and Sanda T: TAL1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia. Leukemia. 37:1969–1981. 2023. View Article : Google Scholar : PubMed/NCBI

Wu Y, Chen K and Liu X, Huang L, Zhao D, Li L, Gao M, Pei D, Wang C and Liu X: Srebp-1 interacts with c-Myc to enhance somatic cell reprogramming. Stem Cells. 34:83–92. 2016. View Article : Google Scholar

Zhou X, Wang G, Tian C, Du L, Prochownik EV and Li Y: Inhibition of DUSP18 impairs cholesterol biosynthesis and promotes anti-tumor immunity in colorectal cancer. Nat Commun. 15:58512024. View Article : Google Scholar : PubMed/NCBI

Liu F, Chen W, Zhang Z, Zeng W, Hu H, Ning S, Liao Z, Liu Y, Zhang H, Fu Q, et al: Targeting Aurora kinase B regulates cholesterol metabolism and enhances chemoimmunotherapy in cholangiocarcinoma. Gut. July 31–2025.Epub ahead of print. View Article : Google Scholar

Gui L, Chen K, Yan J, Chen P, Gao WQ and Ma B: Targeting the mevalonate pathway potentiates NUAK1 inhibition-induced immunogenic cell death and antitumor immunity. Cell Rep Med. 6:1019132025. View Article : Google Scholar : PubMed/NCBI

Singh PK and Mehla K: LXR signaling-mediated cholesterol metabolism reprogramming regulates cancer cell metastasis. Cancer Res. 83:1759–1761. 2023. View Article : Google Scholar : PubMed/NCBI

Mullen PJ, Yu R, Longo J, Archer MC and Penn LZ: The interplay between cell signalling and the mevalonate pathway in cancer. Nat Rev Cancer. 16:718–731. 2016. View Article : Google Scholar : PubMed/NCBI

Seidah NG and Prat A: The multifaceted biology of PCSK9. Endocr Rev. 43:558–582. 2022. View Article : Google Scholar : PubMed/NCBI

Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, Blumenthal R, Danesh J, Smith GD, DeMets D, et al: Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 388:2532–2561. 2016. View Article : Google Scholar : PubMed/NCBI

Xie W, Peng M, Liu Y, Zhang B, Yi L and Long Y: Simvastatin induces pyroptosis via ROS/caspase-1/GSDMD pathway in colon cancer. Cell Commun Signal. 21:3292023. View Article : Google Scholar : PubMed/NCBI

Choi J, Nguyen VH, Przybyszewski E, Song J, Carroll A, Michta M, Almazan E, Simon TG and Chung RT: Statin use and risk of hepatocellular carcinoma and liver fibrosis in chronic liver disease. JAMA Intern Med. 185:522–530. 2025. View Article : Google Scholar : PubMed/NCBI

Nowakowska MK, Lei X, Thompson MT, Shaitelman SF, Wehner MR, Woodward WA, Giordano SH and Nead KT: Association of statin use with clinical outcomes in patients with triple-negative breast cancer. Cancer. 127:4142–4150. 2021. View Article : Google Scholar : PubMed/NCBI

Hemmati S, Saeidikia Z, Seradj H and Mohagheghzadeh A: Immunomodulatory peptides as vaccine adjuvants and antimicrobial agents. Pharmaceuticals (Basel). 17:2012024. View Article : Google Scholar : PubMed/NCBI

Pospiech M, Owens SE, Miller DJ, Austin-Muttitt K, Mullins JGL, Cronin JG, Allemann RK and Sheldon IM: Bisphosphonate inhibitors of squalene synthase protect cells against cholesterol-dependent cytolysins. FASEB J. 35:e216402021. View Article : Google Scholar : PubMed/NCBI

Toyota Y, Yoshioka H, Sagimori I, Hashimoto Y and Ohgane K: Bisphosphonate esters interact with HMG-CoA reductase membrane domain to induce its degradation. Bioorg Med Chem. 28:1155762020. View Article : Google Scholar : PubMed/NCBI

Van Acker HH, Anguille S, Willemen Y, Smits EL and Van Tendeloo VF: Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials. Pharmacol Ther. 158:24–40. 2016. View Article : Google Scholar

Yoneda T, Michigami T, Yi B, Williams PJ, Niewolna M and Hiraga T: Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma. Cancer. 88:2979–2988. 2000. View Article : Google Scholar : PubMed/NCBI

D'Oronzo S, Gregory W, Nicholson S, Chong YK, Brown J and Coleman R: Natural history of stage II/III breast cancer, bone metastasis and the impact of adjuvant zoledronate on distribution of recurrences. J Bone Oncol. 28:1003672021. View Article : Google Scholar : PubMed/NCBI

Liu D, Wong CC, Fu L, Chen H, Zhao L, Li C, Zhou Y, Zhang Y, Xu W, Yang Y, et al: Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target. Sci Transl Med. 10:eaap98402018. View Article : Google Scholar : PubMed/NCBI

Wang Y, Ma X, Xu E, Huang Z, Yang C, Zhu K, Dong Y and Zhang C: Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index. Clin Transl Med. 14:e15862024. View Article : Google Scholar : PubMed/NCBI

Ma L, Huang W, Liang X, Bai G, Wang X, Jiang H, Xin Y, Hu L, Chen X and Liu C: Inhibition of squalene epoxidase linking with PI3K/AKT signaling pathway suppresses endometrial cancer. Cancer Sci. 114:3595–3607. 2023. View Article : Google Scholar : PubMed/NCBI

Kalogirou C, Linxweiler J, Schmucker P, Snaebjornsson MT, Schmitz W, Wach S, Krebs M, Hartmann E, Puhr M, Müller A, et al: MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer. Nat Commun. 12:50662021. View Article : Google Scholar : PubMed/NCBI

Hu LP, Huang W, Wang X, Xu C, Qin WT, Li D, Tian G, Li Q, Zhou Y, Chen S, et al: Terbinafine prevents colorectal cancer growth by inducing dNTP starvation and reducing immune suppression. Mol Ther. 30:3284–3299. 2022. View Article : Google Scholar : PubMed/NCBI

Zhang EB, Zhang X, Wang K, Zhang F, Chen TW, Ma N, Ni QZ, Wang YK, Zheng QW, Cao HJ, et al: Antifungal agent terbinafine restrains tumor growth in preclinical models of hepatocellular carcinoma via AMPK-mTOR axis. Oncogene. 40:5302–5313. 2021. View Article : Google Scholar : PubMed/NCBI

Loibl S, Poortmans P, Morrow M, Denkert C and Curigliano G: Breast cancer. Lancet. 397:1750–1769. 2021. View Article : Google Scholar : PubMed/NCBI

He Q, Kong L, Shi W, Ma D, Liu K, Yang S, Xin Q, Jiang C and Wu J: Ezetimibe inhibits triple-negative breast cancer proliferation and promotes cell cycle arrest by targeting the PDGFR/AKT pathway. Heliyon. 9:e213432023. View Article : Google Scholar : PubMed/NCBI

Wang Y, You S, Su S, Yeon A, Lo EM, Kim S, Mohler JL, Freeman MR and Kim HL: Cholesterol-lowering intervention decreases mTOR complex 2 signaling and enhances antitumor immunity. Clin Cancer Res. 28:414–424. 2022. View Article : Google Scholar :

Bovenga F, Sabbà C and Moschetta A: Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer. Cell Metab. 21:517–526. 2015. View Article : Google Scholar : PubMed/NCBI

Liang H and Shen X: LXR activation radiosensitizes non-small cell lung cancer by restricting myeloid-derived suppressor cells. Biochem Biophys Res Commun. 528:330–335. 2020. View Article : Google Scholar : PubMed/NCBI

Wan W, Hou Y, Wang K, Cheng Y, Pu X and Ye X: The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway. Cell Death Dis. 10:2482019. View Article : Google Scholar : PubMed/NCBI

Munir MT, Ponce C, Santos JM, Sufian HB, Al-Harrasi A, Gollahon LS, Hussain F and Rahman SM: VD₃ and LXR agonist (T0901317) combination demonstrated greater potency in inhibiting cholesterol accumulation and inducing apoptosis via ABCA1-CHOP-BCL-2 cascade in MCF-7 breast cancer cells. Mol Biol Rep. 47:7771–7782. 2020. View Article : Google Scholar : PubMed/NCBI

Tavazoie MF, Pollack I, Tanqueco R, Ostendorf BN, Reis BS, Gonsalves FC, Kurth I, Andreu-Agullo C, Derbyshire ML, Posada J, et al: LXR/ApoE activation restricts innate immune suppression in cancer. Cell. 172:825–840.e18. 2018. View Article : Google Scholar : PubMed/NCBI

Gronich N and Rennert G: Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates. Nat Rev Clin Oncol. 10:625–642. 2013. View Article : Google Scholar : PubMed/NCBI

Kamal A, Boerner J, Assad H, Chen W and Simon MS: The effect of statins on markers of breast cancer proliferation and apoptosis in women with in situ or early-stage invasive breast cancer. Int J Mol Sci. 25:95872024. View Article : Google Scholar : PubMed/NCBI

Graf H, Jüngst C, Straub G, Dogan S, Hoffmann RT, Jakobs T, Reiser M, Waggershauser T, Helmberger T, Walter A, et al: Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma. Digestion. 78:34–38. 2008. View Article : Google Scholar : PubMed/NCBI

Kim Y, Kim TW, Han SW, Ahn JB, Kim ST, Lee J, Park JO, Park YS, Lim HY and Kang WK: A single arm, phase II study of simvastatin plus XELOX and bevacizumab as first-line chemotherapy in metastatic colorectal cancer patients. Cancer Res Treat. 51:1128–1134. 2019. View Article : Google Scholar :

Jian-Yu E, Graber JM, Lu SE, Lin Y, Lu-Yao G and Tan XL: Effect of metformin and statin use on survival in pancreatic cancer patients: A systematic literature review and meta-analysis. Curr Med Chem. 25:2595–2607. 2018. View Article : Google Scholar

Nguyen MKL, Jose J, Wahba M, Bernaus-Esqué M, Hoy AJ, Enrich C, Rentero C and Grewal T: Linking late endosomal cholesterol with cancer progression and anticancer drug resistance. Int J Mol Sci. 23:72062022. View Article : Google Scholar : PubMed/NCBI

Du X, Zhang Y, Jo SR, Liu X, Qi Y, Osborne B, Byrne FL, Smith GC, Turner N, Hoehn KL, et al: Akt activation increases cellular cholesterol by promoting the proteasomal degradation of Niemann-Pick C1. Biochem J. 471:243–253. 2015. View Article : Google Scholar : PubMed/NCBI

Chen K, Zhang X, Sun G, Fang Z, Liao L, Zhong Y, Huang F, Dong M and Luo S: Focusing on the abnormal events of NPC1, NPC2, and NPC1L1 in pan-cancer and further constructing LUAD and KICH prediction models. J Proteome Res. 23:449–464. 2024. View Article : Google Scholar

Liang B, Wu Q, Wang Y, Shi Y, Sun F, Huang Q, Li G, Liu Y, Zhang S, Xu X, et al: Cdc42-driven endosomal cholesterol transport promotes collateral resistance in HER2-positive gastric cancer. Cancer Lett. 587:2167022024. View Article : Google Scholar : PubMed/NCBI

Lin MH, Chao TC, Lee CC, Tung CJ, Yeh CY and Hong JH: Measurement-based Monte Carlo dose calculation system for IMRT pretreatment and on-line transit dose verifications. Med Phys. 36:1167–1175. 2009. View Article : Google Scholar : PubMed/NCBI

Liang D, Minikes AM and Jiang X: Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell. 82:2215–2227. 2022. View Article : Google Scholar : PubMed/NCBI

Jiang X, Stockwell BR and Conrad M: Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 22:266–282. 2021. View Article : Google Scholar : PubMed/NCBI

Lei G, Zhuang L and Gan B: Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 22:381–396. 2022. View Article : Google Scholar : PubMed/NCBI

Li Y, Ran Q, Duan Q, Jin J, Wang Y, Yu L, Wang C, Zhu Z, Chen X, Weng L, et al: 7-Dehydrocholesterol dictates ferroptosis sensitivity. Nature. 626:411–418. 2024. View Article : Google Scholar : PubMed/NCBI

Song YH, Lei HX, Yu D, Zhu H, Hao MZ, Cui RH, Meng XS, Sheng XH and Zhang L: Endogenous chemicals guard health through inhibiting ferroptotic cell death. Biofactors. 50:266–293. 2024. View Article : Google Scholar

Lee J and Roh JL: Cholesterol-ferroptosis nexus: Unveiling novel cancer therapeutic avenues. Cancer Lett. 597:2170462024. View Article : Google Scholar : PubMed/NCBI

Mao X, Xiong J, Cai M, Wang C, He Q, Wang B, Chen J, Xiao Z, Wang B, Han S and Zhang Y: SCARB1 links cholesterol metabolism-mediated ferroptosis inhibition to radioresistance in tumor cells. J Adv Res. January 18–2025.Epub ahead of print. View Article : Google Scholar

Garcia-Bermudez J, Baudrier L, Bayraktar EC, Shen Y, La K, Guarecuco R, Yucel B, Fiore D, Tavora B, Freinkman E, et al: Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death. Nature. 567:118–122. 2019. View Article : Google Scholar : PubMed/NCBI

Wang Y, Calvert AE, Cardenas H, Rink JS, Nahotko D, Qiang W, Ndukwe CE, Chen F, Keathley R, Zhang Y, et al: Nanoparticle targeting in chemo-resistant ovarian cancer reveals dual axis of therapeutic vulnerability involving cholesterol uptake and cell redox balance. Adv Sci (Weinh). 11:e23052122024. View Article : Google Scholar : PubMed/NCBI

Riscal R, Bull CJ, Mesaros C, Finan JM, Carens M, Ho ES, Xu JP, Godfrey J, Brennan P, Johansson M, et al: Cholesterol auxotrophy as a targetable vulnerability in clear cell renal cell carcinoma. Cancer Discovery. 11:3106–3125. 2021. View Article : Google Scholar : PubMed/NCBI

Huang B, Song BL and Xu C: Cholesterol metabolism in cancer: Mechanisms and therapeutic opportunities. Nat Metab. 2:132–141. 2020. View Article : Google Scholar : PubMed/NCBI

Yuan J, Lv T, Yang J, Wu Z, Yan L, Yang J and Shi Y: HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma. Redox Biol. 58:1025462022. View Article : Google Scholar : PubMed/NCBI

Jin H, Zhu M, Zhang D, Liu X, Guo Y, Xia L, Chen Y, Chen Y, Xu R, Liu C, et al: B7H3 increases ferroptosis resistance by inhibiting cholesterol metabolism in colorectal cancer. Cancer Sci. 114:4225–4236. 2023. View Article : Google Scholar : PubMed/NCBI

Noguchi N, Saito Y and Niki E: Lipid peroxidation, ferroptosis, and antioxidants. Free Radic Biol Med. 237:228–238. 2025. View Article : Google Scholar : PubMed/NCBI

Zhao X, Lian X, Xie J and Liu G: Accumulated cholesterol protects tumours from elevated lipid peroxidation in the microenvironment. Redox Biol. 62:1026782023. View Article : Google Scholar : PubMed/NCBI

Li Y, Li Z, Ran Q and Wang P: Sterols in ferroptosis: From molecular mechanisms to therapeutic strategies. Trends Mol Med. 31:36–49. 2025. View Article : Google Scholar

Bai T, Xue P, Shao S, Yan S and Zeng X: Cholesterol depletion-enhanced ferroptosis and immunotherapy via engineered nanozyme. Adv Sci (Weinh). 11:e24058262024. View Article : Google Scholar : PubMed/NCBI

Vitalakumar D, Sharma A and Flora SJS: Ferroptosis: A potential therapeutic target for neurodegenerative diseases. J Biochem Mol Toxicol. 35:e228302021. View Article : Google Scholar : PubMed/NCBI

Shimada K, Skouta R, Kaplan A, Yang WS, Hayano M, Dixon SJ, Brown LM, Valenzuela CA, Wolpaw AJ and Stockwell BR: Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat Chem Biol. 12:497–503. 2016. View Article : Google Scholar : PubMed/NCBI

Yao X, Xie R, Cao Y, Tang J, Men Y, Peng H and Yang W: Simvastatin induced ferroptosis for triple-negative breast cancer therapy. J Nanobiotechnology. 19:3112021. View Article : Google Scholar : PubMed/NCBI

Tang WJ, Xu D, Liang MX, Wo GQ, Chen WQ, Tang JH and Zhang W: Pitavastatin induces autophagy-dependent ferroptosis in MDA-MB-231 cells via the mevalonate pathway. Heliyon. 10:e270842024. View Article : Google Scholar

Zhang R, Zhang L, Fan S and Wang L, Wang B and Wang L: Squalene monooxygenase (SQLE) protects ovarian cancer cells from ferroptosis. Sci Rep. 14:226462024. View Article : Google Scholar : PubMed/NCBI

Mao X, Wang L, Chen Z, Huang H, Chen J, Su J, Li Z, Shen G, Ren Y, Li Z, et al: SCD1 promotes the stemness of gastric cancer stem cells by inhibiting ferroptosis through the SQLE/cholesterol/mTOR signalling pathway. Int J Biol Macromol. 275:1336982024. View Article : Google Scholar : PubMed/NCBI

Debnath J, Gammoh N and Ryan KM: Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 24:560–575. 2023. View Article : Google Scholar : PubMed/NCBI

Vargas JNS, Hamasaki M, Kawabata T, Youle RJ and Yoshimori T: The mechanisms and roles of selective autophagy in mammals. Nat Rev Mol Cell Biol. 24:167–185. 2023. View Article : Google Scholar

Yamamoto H, Zhang S and Mizushima N: Autophagy genes in biology and disease. Nat Rev Genet. 24:382–400. 2023. View Article : Google Scholar : PubMed/NCBI

Rybstein MD, Bravo-San Pedro JM, Kroemer G and Galluzzi L: The autophagic network and cancer. Nat Cell Biol. 20:243–251. 2018. View Article : Google Scholar : PubMed/NCBI

Castellano BM, Thelen AM, Moldavski O, Feltes M, van der Welle RE, Mydock-McGrane L, Jiang X, van Eijkeren RJ, Davis OB, Louie SM, et al: Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex. Science. 355:1306–1311. 2017. View Article : Google Scholar : PubMed/NCBI

Liu F, Tian T, Zhang Z, Xie S, Yang J, Zhu L, Wang W, Shi C, Sang L, Guo K, et al: Long non-coding RNA SNHG6 couples cholesterol sensing with mTORC1 activation in hepatocellular carcinoma. Nat Metab. 4:1022–1040. 2022. View Article : Google Scholar : PubMed/NCBI

Podar K, Tai YT, Cole CE, Hideshima T, Sattler M, Hamblin A, Mitsiades N, Schlossman RL, Davies FE, Morgan GJ, et al: Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells. J Biol Chem. 278:5794–5801. 2003. View Article : Google Scholar

Vilimanovich U, Bosnjak M, Bogdanovic A, Markovic I, Isakovic A, Kravic-Stevovic T, Mircic A, Trajkovic V and Bumbasirevic V: Statin-mediated inhibition of cholesterol synthesis induces cytoprotective autophagy in human leukemic cells. Eur J Pharmacol. 765:415–428. 2015. View Article : Google Scholar : PubMed/NCBI

Yi J, Zhu J, Wu J, Thompson CB and Jiang X: Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc Natl Acad Sci USA. 117:31189–31197. 2020. View Article : Google Scholar : PubMed/NCBI

Guo Y, Zhao M, Bo T, Ma S, Yuan Z, Chen W, He Z, Hou X, Liu J, Zhang Z, et al: Blocking FSH inhibits hepatic cholesterol biosynthesis and reduces serum cholesterol. Cell Res. 29:151–166. 2019. View Article : Google Scholar :

Jun I, Choi YJ, Kim BR, Lee HK, Seo KY and Kim TI: Activation of the mTOR pathway enhances PPARγ/SREBP-mediated lipid synthesis in human meibomian gland epithelial cells. Sci Rep. 14:281182024. View Article : Google Scholar

Hsu JL, Leu WJ, Zhong NS and Guh JH: Autophagic activation and decrease of plasma membrane cholesterol contribute to anticancer activities in non-small cell lung cancer. Molecules. 26:59672021. View Article : Google Scholar : PubMed/NCBI

Zhong Y, Geng F, Mazik L, Yin X, Becker AP, Mohammed S, Su H, Xing E, Kou Y, Chiang CY, et al: Combinatorial targeting of glutamine metabolism and lysosomal-based lipid metabolism effectively suppresses glioblastoma. Cell Rep Med. 5:1017062024. View Article : Google Scholar : PubMed/NCBI

Ng MYW, Charsou C, Lapao A, Singh S, Trachsel-Moncho L, Schultz SW, Nakken S, Munson MJ and Simonsen A: The cholesterol transport protein GRAMD1C regulates autophagy initiation and mitochondrial bioenergetics. Nat Commun. 13:62832022. View Article : Google Scholar : PubMed/NCBI

Shi Y, Ye Z, Lu G, Yang N, Zhang J, Wang L, Cui J, Del Pozo MA, Wu Y, Xia D and Shen HM: Cholesterol-enriched membrane micro-domaindeficiency induces doxorubicin resistancevia promoting autophagy in breast cancer. Mol Ther Oncolytics. 23:311–329. 2021. View Article : Google Scholar : PubMed/NCBI

Shao WQ, Zhu WW, Luo MJ, Fan MH, Li Q, Wang SH, Lin ZF, Zhao J, Zheng Y, Dong QZ, et al: Cholesterol suppresses GOLM1-dependent selective autophagy of RTKs in hepatocellular carcinoma. Cell Rep. 39:1107122022. View Article : Google Scholar : PubMed/NCBI

Yang J, Peng S and Zhang K: ARL4C depletion suppresses the resistance of ovarian cancer to carboplatin by disrupting cholesterol transport and autophagy via notch-RBP-Jκ-H3K4Me3-OSBPL5. Hum Exp Toxicol. 41:96032712211350642022. View Article : Google Scholar

McBrearty N, Cho C, Chen J, Zahedi F, Peck AR, Radaelli E, Assenmacher CA, Pavlak C, Devine A, Yu P, et al: Tumor-suppressive and immune-stimulating roles of cholesterol 25-hydroxylase in pancreatic cancer cells. Mol Cancer Res. 21:228–239. 2023. View Article : Google Scholar :

Liu C, Sun L, Niu N, Hou P, Chen G, Wang H, Zhang Z, Jiang X, Xu Q, Zhao Y, et al: Molecular classification of hormone receptor-positive/HER2-positive breast cancer reveals potential neoadjuvant therapeutic strategies. Signal Transduct Target Ther. 10:972025. View Article : Google Scholar

Leignadier J, Dalenc F, Poirot M and Silvente-Poirot S: Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death. Biochem Pharmacol. 144:18–28. 2017. View Article : Google Scholar : PubMed/NCBI

de Medina P, Paillasse MR, Ségala G, Khallouki F, Brillouet S, Dalenc F, Courbon F, Record M, Poirot M and Silvente-Poirot S: Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands. Chem Phys Lipids. 164:432–437. 2011. View Article : Google Scholar : PubMed/NCBI

Mittal V: Epithelial mesenchymal transition in tumor metastasis. Annu Rev Pathol. 13:395–412. 2018. View Article : Google Scholar : PubMed/NCBI

Huang Y, Hong W and Wei X: The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol. 15:1292022. View Article : Google Scholar : PubMed/NCBI

Jiang S, Wang X, Song D, Liu X, Gu Y, Xu Z, Wang X, Zhang X, Ye Q, Tong Z, et al: Cholesterol induces epithelial-to-mesenchymal transition of prostate cancer cells by suppressing degradation of EGFR through APMAP. Cancer Res. 79:3063–3075. 2019. View Article : Google Scholar : PubMed/NCBI

Shapira KE, Ehrlich M and Henis YI: Cholesterol depletion enhances TGF-β Smad signaling by increasing c-Jun expression through a PKR-dependent mechanism. Mol Biol Cell. 29:2494–2507. 2018. View Article : Google Scholar : PubMed/NCBI

Zheng S, Lin J, Pang Z, Zhang H, Wang Y, Ma L, Zhang H, Zhang X, Chen M, Zhang X, et al: Aberrant cholesterol metabolism and Wnt/β-catenin signaling coalesce via Frizzled5 in supporting cancer growth. Adv Sci (Weinh). 9:e22007502022. View Article : Google Scholar

Ehmsen S and Ditzel HJ: Signaling pathways essential for triple-negative breast cancer stem-like cells. Stem Cells. 39:133–143. 2021. View Article : Google Scholar

Wang XD, Kim C, Zhang Y, Rindhe S, Cobb MH and Yu Y: Cholesterol regulates the tumor adaptive resistance to MAPK pathway inhibition. J Proteome Res. 20:5379–5391. 2021. View Article : Google Scholar : PubMed/NCBI

Aguirre-Portolés C, Feliu J, Reglero G and Ramírez de Molina A: ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin-1-dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetalone. Mol Oncol. 12:1735–1752. 2018. View Article : Google Scholar : PubMed/NCBI

Zhan J, Wang P, Li S, Song J, He H, Wang Y, Liu Z, Wang F, Bai H, Fang W, et al: HOXB13 networking with ABCG1/EZH2/Slug mediates metastasis and confers resistance to cisplatin in lung adenocarcinoma patients. Theranostics. 9:2084–2099. 2019. View Article : Google Scholar : PubMed/NCBI

Bu L, Zhang Z, Chen J, Fan Y, Guo J, Su Y, Wang H, Zhang X, Wu X, Jiang Q, et al: High-fat diet promotes liver tumorigenesis via palmitoylation and activation of AKT. Gut. 73:1156–1168. 2024. View Article : Google Scholar : PubMed/NCBI

Dong J, Kong L, Wang S, Xia M, Zhang Y, Wu J, Yang F, Zuo S and Wei J: Oncolytic adenovirus encoding apolipoprotein A1 suppresses metastasis of triple-negative breast cancer in mice. J Exp Clin Cancer Res. 43:1022024. View Article : Google Scholar : PubMed/NCBI

Li Y, Zhou Y, Huang M, Wang Z, Liu D, Liu J, Fu X, Yang S, Shan S, Yang L, et al: DHCR7 promotes tumorigenesis via activating PI3K/AKT/mTOR signalling pathway in bladder cancer. Cell Signal. 102:1105532023. View Article : Google Scholar

Wan S, He QY, Yang Y, Liu F, Zhang X, Guo X, Niu H, Wang Y, Liu YX, Ye WL, et al: SPARC stabilizes ApoE to induce cholesterol-dependent invasion and sorafenib resistance in hepatocellular carcinoma. Cancer Res. 84:1872–1888. 2024. View Article : Google Scholar : PubMed/NCBI

Tashiro J, Sugiura A, Warita T, Irie N, Dwi Cahyadi D, Ishikawa T and Warita K: CYP11A1 silencing suppresses HMGCR expression via cholesterol accumulation and sensitizes CRPC cell line DU-145 to atorvastatin. J Pharmacol Sci. 153:104–112. 2023. View Article : Google Scholar : PubMed/NCBI

Gómez-López S, Alhendi ASN, Przybilla MJ, Bordeu I, Whiteman ZE, Butler T, Rouhani MJ, Kalinke L, Uddin I, Otter KEJ, et al: Aberrant basal cell clonal dynamics shape early lung carcinogenesis. Science. 388:eads91452025. View Article : Google Scholar : PubMed/NCBI

Lampropoulou DI, Papadimitriou M, Papadimitriou C, Filippou D, Kourlaba G, Aravantinos G and Gazouli M: The role of EMT-related lncRNAs in ovarian cancer. Int J Mol Sci. 24:100792023. View Article : Google Scholar : PubMed/NCBI

Warita K, Ishikawa T, Sugiura A, Tashiro J, Shimakura H, Hosaka YZ, Ohta KI, Warita T and Oltvai ZN: Concomitant attenuation of HMGCR expression and activity enhances the growth inhibitory effect of atorvastatin on TGF-β-treated epithelial cancer cells. Sci Rep. 11:127632021. View Article : Google Scholar

Xiao J, Wang S, Chen L, Ding X, Dang Y, Han M, Zheng Y, Shen H, Wu S, Wang M, et al: 25-Hydroxycholesterol regulates lysosome AMP kinase activation and metabolic reprogramming to educate immunosuppressive macrophages. Immunity. 57:1087–1104.e7. 2024. View Article : Google Scholar : PubMed/NCBI

Sun Z, Xu Y, Shao B, Dang P, Hu S, Sun H, Chen C, Wang C, Liu J, Liu Y and Hu J: Exosomal circPOLQ promotes macrophage M2 polarization via activating IL-10/STAT3 axis in a colorectal cancer model. J Immunother Cancer. 12:e0084912024. View Article : Google Scholar : PubMed/NCBI

Ma Z, Guo L, Pan M, Jiang C, Liu D, Gao Y, Bai J, Jiang P and Liu X: Inhibition of pseudorabies virus replication via upregulated interferon response by targeting 7-dehydrocholesterol reductase. Vet Microbiol. 290:1100002024. View Article : Google Scholar : PubMed/NCBI

Ma X, Bi E, Lu Y, Su P, Huang C, Liu L, Wang Q, Yang M, Kalady MF, Qian J, et al: Cholesterol induces CD8⁺ T cell exhaustion in the tumor microenvironment. Cell Metab. 30:143–156.e5. 2019. View Article : Google Scholar

Yang W, Bai Y, Xiong Y, Zhang J, Chen S, Zheng X, Meng X, Li L, Wang J, Xu C, et al: Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism. Nature. 531:651–655. 2016. View Article : Google Scholar : PubMed/NCBI

Sugi T, Katoh Y, Ikeda T, Seta D, Iwata T, Nishio H, Sugawara M, Kato D, Katoh K, Kawana K, et al: SCD1 inhibition enhances the effector functions of CD8⁺ T cells via ACAT1-dependent reduction of esterified cholesterol. Cancer Sci. 115:48–58. 2024. View Article : Google Scholar

Xu H, Exner BG, Cramer DE, Tanner MK, Mueller YM and Ildstad ST: CD8(+), alphabeta-TCR(+), and gammadelta-TCR(+) cells in the recipient hematopoietic environment mediate resistance to engraftment of allogeneic donor bone marrow. J Immunol. 168:1636–1643. 2002. View Article : Google Scholar : PubMed/NCBI

Lü HZ, Zhu AY, Chen Y, Tang J and Li BQ: Formation and aggregation of lipid rafts in γδ T cells following stimulation with Mycobacterium tuberculosis antigens. Tohoku J Exp Med. 223:193–198. 2011. View Article : Google Scholar

Júnior RFA, Lira GA, Schomann T, Cavalcante RS, Vilar NF, de Paula RCM, Gomes RF, Chung CK, Jorquera-Cordero C, Vepris O, et al: Retinoic acid-loaded PLGA nanocarriers targeting cell cholesterol potentialize the antitumour effect of PD-L1 antibody by preventing epithelial-mesenchymal transition mediated by M2-TAM in colorectal cancer. Transl Oncol. 31:1016472023. View Article : Google Scholar : PubMed/NCBI

Wang Q, Cao Y, Shen L, Xiao T, Cao R, Wei S, Tang M, Du L, Wu H, Wu B, et al: Regulation of PD-L1 through direct binding of cholesterol to CRAC motifs. Sci Adv. 8:eabq47222022. View Article : Google Scholar : PubMed/NCBI

Sun S, Ma J, Zuo T, Shi J, Sun L, Meng C, Shu W, Yang Z, Yao H and Zhang Z: Inhibition of PCSK9: A promising enhancer for Anti-PD-1/PD-L1 immunotherapy. Research (Wash D C). 7:04882024.PubMed/NCBI

Ma X, Bi E, Huang C, Lu Y, Xue G, Guo X, Wang A, Yang M, Qian J, Dong C and Yi Q: Cholesterol negatively regulates IL-9-producing CD8⁺ T cell differentiation and antitumor activity. J Exp Med. 215:1555–1569. 2018. View Article : Google Scholar : PubMed/NCBI

Bai Y, Li T, Wang Q, You W, Yang H, Xu X, Li Z, Zhang Y, Yan C, Yang L, et al: Shaping immune landscape of colorectal cancer by cholesterol metabolites. EMBO Mol Med. 16:334–360. 2024. View Article : Google Scholar : PubMed/NCBI

Baek AE, Yu YA, He S, Wardell SE, Chang CY, Kwon S, Pillai RV, McDowell HB, Thompson JW, Dubois LG, et al: The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells. Nat Commun. 8:8642017. View Article : Google Scholar : PubMed/NCBI

Bruckner M, Dickel D, Singer E and Legler DF: Converse regulation of CCR7-driven human dendritic cell migration by prostaglandin E₂ and liver X receptor activation. Eur J Immunol. 42:2949–2958. 2012. View Article : Google Scholar : PubMed/NCBI

Kitahara CM, Berrington de González A, Freedman ND, Huxley R, Mok Y, Jee SH and Samet JM: Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol. 29:1592–1598. 2011. View Article : Google Scholar : PubMed/NCBI

Mondul AM, Clipp SL, Helzlsouer KJ and Platz EA: Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort. Cancer Causes Control. 21:61–68. 2010.

Nielsen SF, Nordestgaard BG and Bojesen SE: Statin use and reduced cancer-related mortality. N Engl J Med. 367:1792–1802. 2012. View Article : Google Scholar : PubMed/NCBI

Lin Q, Liu W, Xu S and Sun L: Associations of preoperative serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol levels with the prognosis of ovarian cancer. Arch Gynecol Obstet. 305:683–691. 2022. View Article : Google Scholar

Penet MF, Krishnamachary B, Wildes FB, Mironchik Y, Hung CF, Wu TC and Bhujwalla ZM: Ascites volumes and the ovarian cancer microenvironment. Front Oncol. 8:5952018. View Article : Google Scholar

Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Puopolo M and Yu H: Expression of MDR1 in epithelial ovarian cancer and its association with disease progression. Oncol Res. 16:395–403. 2007. View Article : Google Scholar : PubMed/NCBI

Mentella MC, Scaldaferri F, Ricci C, Gasbarrini A and Miggiano GAD: Cancer and mediterranean diet: A review. Nutrients. 11:20592019. View Article : Google Scholar : PubMed/NCBI

Mittelman SD: The role of diet in cancer prevention and chemotherapy efficacy. Annu Rev Nutr. 40:273–297. 2020. View Article : Google Scholar : PubMed/NCBI

Nencioni A, Caffa I, Cortellino S and Longo VD: Fasting and cancer: molecular mechanisms and clinical application. Nat Rev Cancer. 18:707–719. 2018. View Article : Google Scholar : PubMed/NCBI

Li C, Yang L, Zhang D and Jiang W: Systematic review and meta-analysis suggest that dietary cholesterol intake increases risk of breast cancer. Nutr Res. 36:627–635. 2016. View Article : Google Scholar : PubMed/NCBI

Bandera EV, Kushi LH, Moore DF, Gifkins DM and McCullough ML: Dietary lipids and endometrial cancer: The current epidemiologic evidence. Cancer Causes Control. 18:687–703. 2007.PubMed/NCBI

Yang H, Wang F, Hallemeier CL, Lerut T and Fu J: Oesophageal cancer. Lancet. 404:1991–2005. 2024. View Article : Google Scholar : PubMed/NCBI

Jin Y, Yang T, Li D and Ding W: Effect of dietary cholesterol intake on the risk of esophageal cancer: A meta-analysis. J Int Med Res. 47:4059–4068. 2019. View Article : Google Scholar : PubMed/NCBI

Wang QL, Khil J, Hong S, Lee DH, Ha KH, Keum N, Kim HC and Giovannucci EL: Temporal association of total serum cholesterol and pancreatic cancer incidence. Nutrients. 14:49382022. View Article : Google Scholar : PubMed/NCBI

Di Maso M, Augustin LSA, Jenkins DJA, Crispo A, Toffolutti F, Negri E, La Vecchia C, Ferraroni M and Polesel J: Adherence to a cholesterol-lowering diet and the risk of pancreatic cancer: A case-control study. Nutrients. 16:25082024. View Article : Google Scholar : PubMed/NCBI

Hu J, La Vecchia C, de Groh M, Negri E, Morrison H and Mery L; Canadian Cancer Registries Epidemiology Research Group: Dietary cholesterol intake and cancer. Ann Oncol. 23:491–500. 2012. View Article : Google Scholar

Rice MS, Poole EM, Willett WC and Tworoger SS: Adult dietary fat intake and ovarian cancer risk. Int J Cancer. 146:2756–2772. 2020. View Article : Google Scholar :

Chlebowski RT, Anderson GL, Manson JE, Prentice RL, Aragaki AK, Snetselaar L, Beresford SAA, Kuller LH, Johnson K, Lane D, et al: Low-fat dietary pattern and cancer mortality in the women's health initiative (WHI) randomized controlled trial. JNCI Cancer Spectr. 2:pky0652019. View Article : Google Scholar : PubMed/NCBI

Lin X, Liu L, Fu Y, Gao J, He Y, Wu Y and Lian X: Dietary cholesterol intake and risk of lung cancer: A meta-analysis. Nutrients. 10:1852018. View Article : Google Scholar : PubMed/NCBI

Wu Y, Zheng W, Sellers TA, Kushi LH, Bostick RM and Potter JD: Dietary cholesterol, fat, and lung cancer incidence among older women: The Iowa women's health study (United States). Cancer Causes Control. 5:395–400. 1994.PubMed/NCBI

Habis M, Wroblewski K, Bradaric M, Ismail N, Yamada SD, Litchfield L, Lengyel E and Romero IL: Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: A retrospective cohort analysis. PLoS One. 9:e1045212014. View Article : Google Scholar : PubMed/NCBI

Iyengar NM, Gucalp A, Dannenberg AJ and Hudis CA: Obesity and cancer mechanisms: Tumor microenvironment and inflammation. J Clin Oncol. 34:4270–4276. 2016. View Article : Google Scholar : PubMed/NCBI

Yan P and Zhao D: Association between serum total cholesterol and the development of gastric cancer: A two-way two-sample Mendelian randomization study. Medicine (Baltimore). 103:e389002024. View Article : Google Scholar : PubMed/NCBI

Gruenbacher G and Thurnher M: Mevalonate metabolism in immuno-oncology. Front Immunol. 8:17142017. View Article : Google Scholar : PubMed/NCBI

Madan B, Virshup DM, Nes WD and Leaver DJ: Unearthing the Janus-face cholesterogenesis pathways in cancer. Biochem Pharmacol. 196:1146112022. View Article : Google Scholar

Murto MO, Simolin N, Arponen O, Siltari A, Artama M, Visvanathan K, Jukkola A and Murtola TJ: Statin use, cholesterol level, and mortality among females with breast cancer. JAMA Netw Open. 6:e23438612023. View Article : Google Scholar : PubMed/NCBI

Kansal V, Burnham AJ, Kinney BLC, Saba NF, Paulos C, Lesinski GB, Buchwald ZS and Schmitt NC: Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models. J Immunother Cancer. 11:e0059402023. View Article : Google Scholar : PubMed/NCBI

Zhang Y, Wu K, Chan AT, Meyerhardt JA and Giovannucci EL: Long-term statin use, total cholesterol level, and risk of colorectal cancer: A prospective cohort study. Am J Gastroenterol. 117:158–166. 2022. View Article : Google Scholar :

Morote J, Celma A, Planas J, Placer J, de Torres I, Olivan M, Carles J, Reventós J and Doll A: Role of serum cholesterol and statin use in the risk of prostate cancer detection and tumor aggressiveness. Int J Mol Sci. 15:13615–13623. 2014. View Article : Google Scholar : PubMed/NCBI

Hillis AL, Martin TD, Manchester HE, Högström J, Zhang N, Lecky E, Kozlova N, Lee J, Persky NS, Root DE, et al: Targeting cholesterol biosynthesis with statins synergizes with AKT inhibitors in triple-negative breast cancer. Cancer Res. 84:3250–3266. 2024. View Article : Google Scholar : PubMed/NCBI

Trotta F, Avena P, Chimento A, Rago V, De Luca A, Sculco S, Nocito MC, Malivindi R, Fallo F, Pezzani R, et al: Statins reduce intratumor cholesterol affecting adrenocortical cancer growth. Mol Cancer Ther. 19:1909–1921. 2020. View Article : Google Scholar : PubMed/NCBI

Qiu W, Su W, Xu J, Liang M, Ma X, Xue P, Kang Y, Sun ZJ and Xu Z: Immunomodulatory-photodynamic nanostimulators for invoking pyroptosis to augment tumor immunotherapy. Adv Healthc Mater. 11:e22012332022. View Article : Google Scholar : PubMed/NCBI

Nguyen TTT, Ishida CT, Shang E, Shu C, Torrini C, Zhang Y, Bianchetti E, Sanchez-Quintero MJ, Kleiner G, Quinzii CM, et al: Activation of LXRβ inhibits tumor respiration and is synthetically lethal with Bcl-xL inhibition. EMBO Mol Med. 11:e107692019. View Article : Google Scholar

Nguyen TTT, Ishida CT, Shang E, Shu C, Bianchetti E, Karpel-Massler G and Siegelin MD: Activation of LXR receptors and inhibition of TRAP1 causes synthetic lethality in solid tumors. Cancers (Basel). 11:7882019. View Article : Google Scholar : PubMed/NCBI

Cai J, Ye Z, Hu Y, Ye L, Gao L, Wang Y, Sun Q, Tong S, Zhang S, Wu L, et al: Fatostatin induces ferroptosis through inhibition of the AKT/mTORC1/GPX4 signaling pathway in glioblastoma. Cell Death Dis. 14:2112023. View Article : Google Scholar : PubMed/NCBI

Gao S, Shi Z, Li X, Li W, Wang Y, Liu Z and Jiang J: Fatostatin suppresses growth and enhances apoptosis by blocking SREBP-regulated metabolic pathways in endometrial carcinoma. Oncol Rep. 39:1919–1929. 2018.PubMed/NCBI

Lee HJ, Li J, Vickman RE, Li J, Liu R, Durkes AC, Elzey BD, Yue S, Liu X, Ratliff TL and Cheng JX: Cholesterol esterification inhibition suppresses prostate cancer metastasis by impairing the Wnt/β-catenin pathway. Mol Cancer Res. 16:974–985. 2018. View Article : Google Scholar : PubMed/NCBI

Zhang Y, Li L, Chu F, Wu H, Xiao X, Ye J and Li K: Itraconazole inhibits tumor growth via CEBPB-mediated glycolysis in colorectal cancer. Cancer Sci. 115:1154–1169. 2024. View Article : Google Scholar : PubMed/NCBI

Aftab BT, Dobromilskaya I, Liu JO and Rudin CM: Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer. Cancer Res. 71:6764–6772. 2011. View Article : Google Scholar : PubMed/NCBI

Wang S, Link F, Han M, Chaudhary R, Asimakopoulos A, Liebe R, Yao Y, Hammad S, Dropmann A, Krizanac M, et al: The interplay of TGF-β1 and cholesterol orchestrating hepatocyte cell fate, EMT, and signals for HSC activation. Cell Mol Gastroenterol Hepatol. 17:567–587. 2024. View Article : Google Scholar

Wang Y, Zhou X, Lei Y, Chu Y, Yu X, Tong Q, Zhu T, Yu H, Fang S, Li G, et al: NNMT contributes to high metastasis of triple negative breast cancer by enhancing PP2A/MEK/ERK/c-Jun/ABCA1 pathway mediated membrane fluidity. Cancer Lett. 547:2158842022. View Article : Google Scholar : PubMed/NCBI

Brindisi M, Frattaruolo L, Fiorillo M, Dolce V, Sotgia F, Lisanti MP and Cappello AR: New insights into cholesterol-mediated ERRα activation in breast cancer progression and pro-tumoral microenvironment orchestration. FEBS J. 290:1481–1501. 2023. View Article : Google Scholar

Jin H, He Y, Zhao P, Hu Y, Tao J, Chen J and Huang Y: Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery. Theranostics. 9:265–278. 2019. View Article : Google Scholar :

Gao CQ, Chu ZZ, Zhang D, Xiao Y, Zhou XY, Wu JR, Yuan H, Jiang YC, Chen D, Zhang JC, et al: Serine/threonine kinase TBK1 promotes cholangiocarcinoma progression via direct regulation of β-catenin. Oncogene. 42:1492–1507. 2023. View Article : Google Scholar : PubMed/NCBI

Wen Q, Xie X, Chen C, Wen B, Liu Y, Zhou J, Lin X, Jin H and Shi K: Lipid reprogramming induced by the NNMT-ABCA1 axis enhanced membrane fluidity to promote endometrial cancer progression. Aging (Albany NY). 15:11860–11874. 2023. View Article : Google Scholar : PubMed/NCBI

Dong G, Huang X, Jiang S, Ni L, Ma L, Zhu C and Chen S: SCAP mediated GDF15-induced invasion and EMT of esophageal cancer. Front Oncol. 10:5647852020. View Article : Google Scholar : PubMed/NCBI

Chen W, Zhang Q, Dai X, Chen X, Zhang C, Bai R, Chen Y, Zhang K, Duan X, Qiao Y, et al: PGC-1α promotes colorectal carcinoma metastasis through regulating ABCA1 transcription. Oncogene. 42:2456–2470. 2023. View Article : Google Scholar : PubMed/NCBI

Qin WH, Yang ZS, Li M, Chen Y, Zhao XF, Qin YY, Song JQ, Wang BB, Yuan B, Cui XL, et al: High serum levels of cholesterol increase antitumor functions of nature killer Cells and reduce growth of liver tumors in mice. Gastroenterology. 158:1713–1727. 2020. View Article : Google Scholar : PubMed/NCBI

Esposito G, Augustin LSA, Jenkins DJA, Ferraroni M, Parazzini F, Crispo A, Dal Maso L, Negri E, La Vecchia C, Polesel J and Di Maso M: Adherence to a cholesterol-lowering diet and the risk of female hormone-related cancers: An analysis from a case-control study network. BJOG. 132:1791–1801. 2025. View Article : Google Scholar : PubMed/NCBI

Furberg AS, Veierød MB, Wilsgaard T, Bernstein L and Thune I: Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst. 96:1152–1160. 2004. View Article : Google Scholar : PubMed/NCBI

Di Maso M, Dal Maso L, Augustin LSA, Puppo A, Falcini F, Stocco C, Mattioli V, Serraino D and Polesel J: Adherence to the mediterranean diet and mortality after breast cancer. Nutrients. 12:36492020. View Article : Google Scholar : PubMed/NCBI

Maddineni G, Xie JJ, Brahmbhatt B and Mutha P: Diet and carcinogenesis of gastric cancer. Curr Opin Gastroenterol. 38:588–591. 2022. View Article : Google Scholar : PubMed/NCBI

Bidoli E, La Vecchia C, Montella M, Maso LD, Conti E, Negri E, Scarabelli C, Carbone A, Decarli A and Franceschi S: Nutrient intake and ovarian cancer: An Italian case-control study. Cancer Causes Control. 13:255–261. 2002.PubMed/NCBI

Quan L, Liu Y, Cui W, Wang X, Zhang W, Wang Z, Guo C, Lu C, Hu F and Chen X: The associations between serum high-density lipoprotein cholesterol levels and malignant behavior in pancreatic neuroendocrine neoplasms. Lipids Health Dis. 21:582022. View Article : Google Scholar : PubMed/NCBI

de Martino M, Leitner CV, Seemann C, Hofbauer SL, Lucca I, Haitel A, Shariat SF and Klatte T: Preoperative serum cholesterol is an independent prognostic factor for patients with renal cell carcinoma (RCC). BJU Int. 115:397–404. 2015. View Article : Google Scholar

Li L, Yu Z, Ren J and Niu T: Low cholesterol levels are associated with increasing risk of plasma cell neoplasm: A UK biobank cohort study. Cancer Med. 12:20964–20975. 2023. View Article : Google Scholar : PubMed/NCBI

Yang Z, Tang H, Lu S, Sun X and Rao B: Relationship between serum lipid level and colorectal cancer: A systemic review and meta-analysis. BMJ Open. 12:e0523732022. View Article : Google Scholar : PubMed/NCBI

Yuan F, Wen W, Jia G, Long J, Shu XO and Zheng W: Serum lipid profiles and cholesterol-lowering medication use in relation to subsequent risk of colorectal cancer in the UK biobank cohort. Cancer Epidemiol Biomarkers Prev. 32:524–530. 2023. View Article : Google Scholar : PubMed/NCBI

Karayama M, Inui N, Inoue Y, Yoshimura K, Mori K, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, et al: Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer. Cancer Immunol Immunother. 71:203–217. 2022. View Article : Google Scholar :

Narii N, Zha L, Komatsu M, Kitamura T, Sobue T and Ogawa T: Cholesterol and breast cancer risk: A cohort study using health insurance claims and health checkup databases. Breast Cancer Res Treat. 199:315–322. 2023. View Article : Google Scholar : PubMed/NCBI

Yang Z, Zhang D, Sima X, Fu Y, Zeng H, Hu Z, Hou J, Pan Y, Zhang Y, Zhou Z, et al: Levels of pretreatment serum lipids predict responses to PD-1 inhibitor treatment in advanced intrahepatic cholangiocarcinoma. Int Immunopharmacol. 115:1096872023. View Article : Google Scholar : PubMed/NCBI

Huang F, Li S, Wang X, Wang C, Pan X, Chen X, Zhang W and Hong J: Serum lipids concentration on prognosis of high-grade glioma. Cancer Causes Control. 34:801–811. 2023.PubMed/NCBI

Min J, Wu Y, Huang S, Li Y, Lv X, Tang R, Zhao H and Wang J: Serum cholesterol level as a predictive biomarker for prognosis of neuroblastoma. BMC Pediatr. 24:2052024. View Article : Google Scholar : PubMed/NCBI

Zhang C, Li Y, Wang Y, Hu S, Liu Y, Liang X, Chen ZJ, Zhang Y and Zhao H: Genetic associations of metabolic factors and therapeutic drug targets with polycystic ovary syndrome. J Adv Res. 75:581–590. 2025. View Article : Google Scholar

Qian L, Qian B, Xu J, Yang J, Wu G, Zhao Y, Liu Q, Yuan Z, Fan Y and Li H: Clinical relevance of serum lipids in the carcinogenesis of oral squamous cell carcinoma. BMC Oral Health. 23:2002023. View Article : Google Scholar : PubMed/NCBI

Leeper H, Viall A, Ruaux C and Bracha S: Preliminary evaluation of serum total cholesterol concentrations in dogs with osteosarcoma. J Small Anim Pract. 58:562–569. 2017. View Article : Google Scholar : PubMed/NCBI